Coegin Pharma (NGM:COEGIN) 3-Year EBITDA Growth Rate : 57.20% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Coegin Pharma 3-Year EBITDA Growth Rate?

Coegin Pharma's EBITDA per Share for the three months ended in Dec. 2023 was kr-0.67.

During the past 3 years, the average EBITDA Per Share Growth Rate was 57.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 77.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Coegin Pharma was 94.80% per year. The lowest was 9.30% per year. And the median was 66.25% per year.

Competitive Comparison of Coegin Pharma's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Coegin Pharma's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coegin Pharma's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coegin Pharma's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Coegin Pharma's 3-Year EBITDA Growth Rate falls into.

Coegin Pharma 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Coegin Pharma (NGM:COEGIN) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Coegin Pharma 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Coegin Pharma's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Coegin Pharma (NGM:COEGIN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Coegin Pharma (NGM:COEGIN) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Birger Jarlsgatan 18 A, 4th Floor, Stockholm, SWE, 114 34

Website

https://www.coeginpharma.com

Coegin Pharma AB is a biotechnology company that focuses on the development of small molecule therapies for the treatment of inflammatory diseases such as cancer and kidney disease.

Coegin Pharma (NGM:COEGIN) Headlines

No Headlines